HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon

BACKGROUND: With the phase-out of stavudine (d4T), change to first-line regimens with zidovudine (AZT) or tenofovir (TDF) in resource-limited settings (RLS) might increase risks of cross-resistance to nucleos(t) ide reverse transcriptase inhibitors (NRTI). This would restrict the scope of switching...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:BMC Infect Dis
Κύριοι συγγραφείς: Takou, Desire, Fokam, Joseph, Teto, Georges, Santoro, Maria-Mercedes, Ceccherini-Silberstein, Francesca, Nanfack, Aubin Joseph, Sosso, Samuel Martin, Dambaya, Béatrice, Salpini, Romina, Billong, Serge Clotaire, Gori, Caterina, Fokunang, Charles Ntungwen, Cappelli, Giulia, Colizzi, Vittorio, Perno, Carlo-Federico, Ndjolo, Alexis
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: BioMed Central 2019
Θέματα:
Research Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6419466/
https://ncbi.nlm.nih.gov/pubmed/30871487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-019-3871-0
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια